Home » Health » Center for Genetic Engineering and Biotechnology: Contributions to Science and Vaccines in Cuba and Beyond

Center for Genetic Engineering and Biotechnology: Contributions to Science and Vaccines in Cuba and Beyond

Center for Genetic Engineering and Biotechnology. Photo: Taken by Workers

The Prime Minister of Cuba, Manuel Marrero, today recognized the work and contributions to the science of Center for Genetic Engineering and Biotechnology (CIGB)on the occasion of the 37th anniversary of its creation.

Through his Twitter account, the head of government sent congratulations to the CIGB work group, founded on the initiative of the historic leader of the Cuban Revolution, Fidel Castro.

«You are the pride of our science. With its products, many human lives have been saved in Cuba and other parts of the world.”highlighted Marrero on the social network.

The CIGB prints its name in the scientific history of the island and the world for the development of various drugs and vaccines such as two of the five Cuban immunogens against Covid-19: Mambisa and Abdala.

Abdala, the first vaccine conceived in Latin America, demonstrated 92.28 percent efficacy in its phase III clinical trial and millions of doses have already been administered in the Caribbean nation and in others such as Venezuela, Nicaragua, the Sahrawi Arab Democratic Republic and Vietnam.. Data from the center itself indicate that some 40 million doses of the Abdala vaccine were delivered to the Cuban Health System for mass vaccination against Covid-19.

Mambisa, for its part, is among the immunogens designed globally to be administered nasally and thus attack the main entry of the SARS-CoV-2 coronavirus, which causes the Covid-19 pandemic.

In charge of the Center have been leading scientific products in the Caribbean nation, such as the vaccine against hepatitis B, the epidermal growth factor, the Heberpenta vaccine and the preparation of streptokinase, obtained for the first time in the world.

It also has to its credit one of the most recognized medicines in the international arena: Heberprot-P, a unique and exclusive drug, designed to treat diabetic foot ulcers and which reduces the risk of amputation.

With information from Prensa Latina

Latest Radio Angulo entries (see all)
2023-07-01 14:05:59
#Genetic #Engineering #Center #years #outstanding #scientific #work #Radio #Angulo

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.